News
The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and ...
From M&A to MDUFA and the developing market in renal denervation, MedTech Dive covers the key issues for the industry to ...
Top roles at Intuitive, Boston Scientific, Dexcom and others changed hands this year. Read MedTech Dive’s roundup for all the ...
The medtech trade group wants the CMS to take “bold action” to cut the lag between FDA authorization of devices and Medicare ...
Traditional insulin pumps can help with nighttime glucose control, but they can be complex, expensive and require lifestyle ...
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being ...
New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured ...
The trade group wants the U.S. to eliminate tariffs on medical technologies, warning that “patients cannot be collateral ...
The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...
The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results